"patients treated" trang 14 - tải miễn phí từ tailieunhanh
Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab

Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
8    61    1
Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy

Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy
11    36    1
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer

Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
8    55    1
Outcomes for hospitalized patients with idiopathic pulmonary fbrosis treated with antifibrotic medications

Outcomes for hospitalized patients with idiopathic pulmonary fbrosis treated with antifibrotic medications
14    55    1
Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients

Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
9    50    1
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)

Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)
11    53    3
Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: A multicenter retrospective study

Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: A multicenter retrospective study
12    34    3
High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine

High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine
13    36    3
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: A retrospective study

Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: A retrospective study
10    49    3
Chronic liver disease and cirrhosis increase morbidity in geriatric patients treated surgically for hip fractures: Analysis of the US Nationwide Inpatient Sample

Chronic liver disease and cirrhosis increase morbidity in geriatric patients treated surgically for hip fractures: Analysis of the US Nationwide Inpatient Sample
9    18    1
Long-term treated intensive care patients outcomes: The one-year mortality rate, quality of life, health care use and long-term complications as reported by general practitioners

Long-term treated intensive care patients outcomes: The one-year mortality rate, quality of life, health care use and long-term complications as reported by general practitioners
8    32    1
Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer’s vs. Dextran - a randomized controlled trial

Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer’s vs. Dextran - a randomized controlled trial
8    17    1
Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy

Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy
8    19    1
NT-proBNP in cardiopulmonary resuscitated patients treated with mild therapeutic hypothermia is not independently associated with mortality: A retrospective observational study

NT-proBNP in cardiopulmonary resuscitated patients treated with mild therapeutic hypothermia is not independently associated with mortality: A retrospective observational study
9    26    1
Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: Protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)

Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: Protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)
7    33    1
Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review

Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review
12    31    1
A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation

A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation
11    22    1
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis

T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis
7    25    1
Rationale and design of ON-TRK: A novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

Rationale and design of ON-TRK: A novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
11    22    1
Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: A proof-of-concept study

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: A proof-of-concept study
13    29    1